Home › Markets › Industrials › SMG

Scotts Miracle-Gro Company (The) (SMG)

SMG trades on NYSE in Industrials, Agricultural Chemicals. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$50.10
+0.32% on the day
Market cap
$2.9B
Mid cap
Revenue · 2025
$3.4B
-3.9% on 2024
Net income · 2025
$145.2M
4.3% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.

Profile

FieldValue
TickerSMG on NYSE
SectorIndustrials
IndustryAgricultural Chemicals
CountryUnited States
IPO year1992
SEC CIK0000825542
SEC industry codeAgricultural Chemicals
Incorporated inOH

Financials · 2025

LineValue
Revenue$3.4B
Net income$145.2M
Operating income$358.6M
Net margin4.3%
Operating margin10.5%
Revenue growth-3.9%
Cash$8.3M
Total assets$3.0B
P/E (computed)20.1×
P/S (computed)0.9×

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-3ASR2025-01-10
Latest annual report10-K2025-11-25
Latest quarterly / interim10-Q2026-08-05
Latest current report8-K/A2026-09-25
Latest proxyDEFA14A2025-12-17

Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+0.6%
1 month-11.4%
3 months-32.3%
Year to date-14.8%
1 year-10.3%
From 52-week high-32.3%

Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Agricultural Chemicals

TickerCompanyPriceDayMarket cap
MOSMosaic Company (The)$19.18+1.75%$6.1B
UANCVR Partners LP Common Units representing Limited Partner Interests$126.21+0.57%$1.3B
ICLICL Group Ltd.$4.98+0.81%$6.4B
CFCF Industries Holdings Inc.$117.25+2.33%$17.7B
NTRNutrien Ltd. Common Shares$69.68+2.47%$33.6B
CBUSCibus Inc.$1.41-4.73%$107.8M
AVDAmerican Vanguard Corporation Common Stock ($0.10 Par Value)$1.33-5.67%$39.2M
BIOXBioceres Crop Solutions Corp.$0.3250-1.81%$20.7M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier